Skip to Content

Join the 'Chronic Obstructive Pulmonary Disease' group to help and get support from people like you.

Chronic Obstructive Pulmonary Disease News

Related terms: Bronchitis, Chronic, Bronchitis with Airway Obstruction, Chronic Bronchitis, Chronic Obstructive Airway Disease, Chronic Obstructive Lung Disease, Emphysema, COPD

Study Casts Doubt on Effectiveness of COPD Drug

Posted 7 days ago by Drugs.com

TUESDAY, Feb. 2, 2016 – A widely used drug may not significantly reduce the amount of time that patients with the lung condition COPD require mechanical help to breathe, a new study suggests. COPD (chronic obstructive pulmonary disease) – which is often related to smoking – includes emphysema, chronic bronchitis or a combination of the two. Common symptoms include difficulty breathing, chronic cough, wheezing and phlegm production. Over time, the condition can prove fatal. The drug acetazolamide has been used for decades to help COPD patients breathe when they develop a dangerous condition called metabolic alkalosis. However, the French study authors said that, until now, there's been no clinical trial to prove that the drug is actually effective in such cases. To try to remedy that situation, the new study included 380 French COPD patients who were expected to receive mechanical ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Diamox, Acetazolamide, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Diamox Sequels

Higher Fiber Intake May Improve Lung Function

Posted 11 days ago by Drugs.com

THURSDAY, Jan. 28, 2016 – Eating a fiber-rich diet may help protect you against lung disease, a new study suggests. "Lung disease is an important public health problem, so it's important to identify modifiable risk factors for prevention," study author Corrine Hanson, an associate professor of medical nutrition at the University of Nebraska Medical Center, said in a journal news release. "However, beyond smoking very few preventative strategies have been identified. Increasing fiber intake may be a practical and effective way for people to have an impact on their risk of lung disease," she added. The findings were published recently in the Annals of the American Thoracic Society. Researchers looked at federal government data from almost 2,000 American adults. They were between 40 and 79 years old. The researchers found that 68 percent of those who had the highest fiber consumption ... Read more

Related support groups: Asthma, Chronic Obstructive Pulmonary Disease, Cold Symptoms, Upper Respiratory Tract Infection, Vitamin/Mineral Supplementation and Deficiency, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Aspiration Pneumonia, Respiratory Tract Disease, Dietary Fiber Supplementation, Respiratory Distress Syndrome, Respiratory Failure

Long-Term Smog Exposure May Boost Heart, Lung Disease Deaths

Posted 14 days ago by Drugs.com

MONDAY, Jan. 25, 2016 – Long-term exposure to ozone air pollution – commonly known as smog – may increase the risk of death from heart and lung diseases, a new study indicates. Researchers reviewed data from a U.S. study that began in 1982 and found that for every additional 10 parts per billion (ppb) in long-term ozone exposure, adults were 12 percent more likely to die from lung disease. In addition, they were 3 percent more likely to die from heart disease, and 2 percent more likely to die from any cause, according to the study. It was published online recently in the American Journal of Respiratory and Critical Care Medicine. Pollution specifically attributed to traffic was linked to a 41 percent increased risk of dying from heart disease with each 10 ppb increase in exposure, the investigators found. "About 130 million people are living in areas that exceed the National Ambient ... Read more

Related support groups: Cough, Heart Disease, Chronic Obstructive Pulmonary Disease, Bronchiectasis, Cardiovascular Risk Reduction, Respiratory Tract Disease, Ischemic Heart Disease, Abnormal Electrocardiogram

Coils in Lungs Might Boost Ability to Exercise With Emphysema

Posted 12 Jan 2016 by Drugs.com

TUESDAY, Jan. 12, 2016 – Implanting coils in the lungs may help improve the ability to exercise in people with severe emphysema, a new study suggests. Emphysema is a type of chronic obstructive pulmonary disease (COPD) that damages the airways and makes it difficult to breathe. Current treatments for severe emphysema have limited effectiveness. Lung volume reduction surgery can help, but carries a risk of complications and death, the study authors explained. Dr. Gaetan Deslee, of Reims University Hospital in France, and colleagues recruited 100 patients for the study. Fifty patients received usual care – rehabilitation and bronchodilators with or without inhaled corticosteroids and oxygen. The remaining 50 received usual care and also had coils placed in their lungs. The researchers said the coils were placed in the lungs using an endoscope – a slender, flexible device inserted into ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Bronchitis, Upper Respiratory Tract Infection, Bronchiectasis, Respiratory Tract Disease, Respiratory Distress Syndrome, Diagnosis and Investigation, Respiratory Failure, Respiratory Arrest

Implanted Lung Valves Show Promise in Some Emphysema Patients

Posted 9 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 9, 2015 – New research suggests that more careful selection of patients could help improve the success rate of valves implanted into the lungs of people with emphysema. The valves aim to improve breathing, allowing patients with the chronic lung disease to be more active and to perhaps survive longer. Previous research into the valves has been mixed, but the new Dutch study found that they work more effectively if physicians are more selective about which patients get them. "The results are relatively impressive," said lung physician Dr. Gary Hunninghake, an assistant professor at Harvard Medical School in Boston. "These are benefits that physicians would want to get, and patients might feel better. This could result in people being more enthusiastic about this technique." However, the valves come with a risk of serious side effects, the study authors noted, and the ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Respiratory Tract Disease, Diagnosis and Investigation, Respiratory Failure, Mechanical Ventilation, Bronchospastic Disease, Respiratory Arrest

E-Cigarettes May Contain Chemicals Linked to Lung Disease

Posted 8 Dec 2015 by Drugs.com

TUESDAY, Dec. 8, 2015 – Many electronic cigarettes contain flavoring chemicals that may cause lung disease, researchers say. A team from Harvard School of Public Health in Boston tested 51 types of flavored e-cigarettes and liquids. The investigators found that 47 (more than 75 percent) of them contained diacetyl. The chemical has been linked to a severe lung disease called bronchiolitis obliterans, also known as "popcorn lung" because it was first diagnosed in workers who inhaled artificial-butter flavoring in factories making microwave popcorn. Two other related flavoring chemicals that may pose a lung hazard were also found in many of the flavored e-cigarettes and liquids tested, according to researchers led by Joseph Allen, an assistant professor of exposure assessment science at the school. One such flavoring chemical, acetoin, was detected in 46 of the flavors while another, ... Read more

Related support groups: Cough, Smoking, Chronic Obstructive Pulmonary Disease, Smoking Cessation, Nicotine, Nicorette, Nicoderm CQ, Poisoning, Nicotrol Inhaler, Commit, Bronchiectasis, Respiratory Tract Disease, Toxic Reactions Incl Drug and Substance Abuse, Habitrol, Nicotrol NS, ProStep, Nicotrol TD, Nicorelief, Nicorette DS

Agricultural Pesticides May Affect Kids' Breathing

Posted 3 Dec 2015 by Drugs.com

THURSDAY, Dec. 3, 2015 – Early exposure to widely used pesticides may harm children's lungs, a new study says. Previous research has looked at the harmful effect of organophosphate pesticides – chemicals that target the nervous system – on adult agricultural workers. This new study looked at children living in an agricultural area where the organophosphates are used. "This is the first evidence suggesting that children exposed to organophosphates have poorer lung function," said study senior author Brenda Eskenazi, a professor of epidemiology and of maternal and child health at the University of California, Berkeley. For this study, researchers measured levels of organophosphate pesticides in urine samples collected on five occasions from 279 children in California's Salinas Valley between the ages of 6 months and 5 years. The area is an agricultural hub, producing lettuce, grapes, ... Read more

Related support groups: Cough, Asthma, Chronic Obstructive Pulmonary Disease, Bronchitis, Pneumonia, Asthma - Maintenance, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Asthma - Acute, Sore Throat, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Respiratory Tract Disease, Croup, Respiratory Distress Syndrome, Diagnosis and Investigation, Respiratory Failure, Reversible Airways Disease, Reversible Airways Disease - Maintenance

Health Tip: The Benefits of Oxygen Therapy

Posted 30 Nov 2015 by Drugs.com

-- Oxygen therapy provides extra oxygen if you have a health condition that prevents you from getting enough. The National Heart Lung and Blood Institute mentions these potential benefits: Improved shortness of breath. Improved sleep, if you're bothered by a breathing disorder during slumber. Improved quality of life and lifespan for some people with chronic obstructive pulmonary disease (COPD). Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Oxygen, Respiratory Tract Disease

Smog Raises Heart Risks in Those With Diabetes, Study Says

Posted 25 Nov 2015 by Drugs.com

WEDNESDAY, Nov. 25, 2015 – Long periods of exposure to air pollution – including dust and car exhaust – heightens heart risks for women with diabetes, a large, new study indicates. Building on prior research linking shorter exposures to air pollution to higher heart disease in the general population, the scientists found that those with diabetes are especially vulnerable. "People respond differently to levels of air pollution, and our study was uniquely suited to look at this," said study author Jaime Hart, an assistant professor of medicine at Brigham and Women's Hospital in Boston. "There's pretty robust literature about the short-term effects of air pollution suggesting those with diabetes are at risk, so it's nice that our results actually went along with [that]," she added. The study was published Nov. 25 in the Journal of the American Heart Association. Heart disease is a ... Read more

Related support groups: Diabetes, Type 2, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, Respiratory Tract Disease, Cardiovascular Risk Reduction

FDA Approves Seebri Neohaler (glycopyrrolate) for COPD

Posted 4 Nov 2015 by Drugs.com

EAST HANOVER, N.J., Oct. 29, 2015 Novartis announced today that the US Food and Drug Administration (FDA) has approved Seebri Neohaler (glycopyrrolate) inhalation powder 15.6 mcg as a stand-alone monotherapy for COPD. Novartis expects that Seebri Neohaler will be available in the first quarter of 2016. Seebri is delivered via the low resistance Neohaler inhaler, which makes it suitable for patients with different severities of airflow limitation. About Seebri Neohaler Seebri Neohaler, previously known as NVA237, is a twice-daily long-acting muscarinic antagonist (LAMA) for the long-term maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema. Glycopyrrolate (also known as glycopyrronium bromide) was exclusively licensed to Novartis in April 2005 by Vectura and its co-development partner Sosei. About Novartis Respiratory ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Glycopyrrolate, Seebri Neohaler

FDA Approves Utibron Neohaler (indacaterol/glycopyrrolate) for COPD

Posted 4 Nov 2015 by Drugs.com

EAST HANOVER, N.J., Oct. 29, 2015 Novartis announced today that the US Food and Drug Administration (FDA) has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD. "Patients have told us about the tremendous impact their COPD can have on everyday activities," said Christi Shaw, US Country Head, President of Novartis Corporation and Novartis Pharmaceuticals Corporation. "With this approval, the COPD community now has a new medicine that can help so many patients by improving not only their symptoms, but also their health-related quality of life. This means the possibility of doing things that matter ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Glycopyrrolate/indacaterol, Utibron Neohaler

VW Emissions Scandal May Cost 60 U.S. Lives, Study Claims

Posted 29 Oct 2015 by Drugs.com

THURSDAY, Oct. 29, 2015 – The Volkswagen emissions scandal will directly cause 60 premature deaths in the United States and hundreds of millions of dollars in health care expenses and other costs, U.S. researchers claim. The German automaker has admitted to using software to evade emissions standards in more than 482,000 diesel vehicles in the United States. According to the authors of the new study, this enabled VW cars to emit 40 times more pollution than permitted by the U.S. Clean Air Act. In their new analysis, researchers at Massachusetts Institute of Technology (MIT) and Harvard University took that excess pollution figure and multiplied it by the number of affected vehicles sold in the United States, to determine the public health consequences of VW's action. They calculated that about 60 Americans will die 10 to 20 years prematurely because of the emissions standards breach. ... Read more

Related support groups: Heart Disease, Chronic Obstructive Pulmonary Disease, Bronchitis, Respiratory Tract Disease

People With Schizophrenia Face Much Higher Risk of Early Death

Posted 28 Oct 2015 by Drugs.com

WEDNESDAY, Oct. 28, 2015 – American adults with schizophrenia face a much higher risk of an early death, particularly from heart and lung diseases associated with smoking, a new study finds. The rise in risk "is evident in early adulthood and persists into later life. Especially high risks of mortality were observed from diseases for which tobacco use is a key risk factor," concluded a team led by Dr. Mark Olfson, of Columbia University in New York City. The issue is a familiar one, said one expert who reviewed the new findings. "Individuals with mental illnesses like schizophrenia and bipolar disorder die, on average, approximately two decades early, and primarily from cardiovascular disease and other preventable chronic illnesses," said Dr. Michael Compton, chair of psychiatry at Lenox Hill Hospital in New York City. In the study, Olfson's team looked at data from more than 1 million ... Read more

Related support groups: Diabetes, Type 2, Cancer, Chronic Obstructive Pulmonary Disease, Schizophrenia, Pneumonia

Health Tip: What's Behind That Cough?

Posted 30 Sep 2015 by Drugs.com

-- A cough is the body's reaction to an irritant in the airways. The U.S. National Heart Lung and Blood Institute mentions possible cough triggers: Allergens, such as dust, dander, pollen or mold. Irritants, such as cigarette smoke or substances with a strong fragrance, such as air fresheners or perfumes. A medical condition, such as the common cold, pneumonia or the flu. A long-term medical condition, such as chronic obstructive pulmonary disorder (COPD), lung cancer, heart failure or asthma. A side effect of medication, including beta blockers and ACE inhibitors. Read more

Related support groups: Lisinopril, Cough, Allergic Reactions, Allergies, Asthma, Smoking, Chronic Obstructive Pulmonary Disease, Influenza, Pneumonia, Ramipril, Cold Symptoms, Enalapril, Benazepril, Cough and Nasal Congestion, Perindopril, Sore Throat, Zestril, Quinapril, Vasotec, Altace

Differences Found in Smokers, Nonsmokers Who Develop Lung Cancer

Posted 28 Sep 2015 by Drugs.com

SUNDAY, Sept. 27, 2015 – A new study has identified significant differences between lung cancer patients who smoke and those who don't. Smoking is the main risk factor for non-small cell lung cancer, but nonsmokers can get it too and rates of the disease among nonsmokers are rising in many countries, according to researchers at the Portuguese Institute of Oncology in Lisbon. The investigators compared more than 1,400 Portuguese patients with this type of lung cancer and found that nonsmokers were more likely than smokers to be women and to have adenocarcinoma, the most common form of non-small cell lung cancer. The nonsmokers were also less likely to have chronic obstructive pulmonary disease (COPD), heart disease, previous cancer of the larynx, or weight loss, the results showed. In addition, nonsmokers lived about twice as long after diagnosis, an average of 51 months compared to 25 ... Read more

Related support groups: Cancer, Heart Disease, Smoking, Chronic Obstructive Pulmonary Disease, Weight Loss, Smoking Cessation, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

Page 1 2 3 4 5 6 7 8 9 Next

Ask a Question

Further Information

Related Condition Support Groups

Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute, Alpha-1 Proteinase Inhibitor Deficiency, Respiratory Tract Disease

Related Drug Support Groups

prednisone, Symbicort, montelukast, Daliresp, Bronchial, Breo Ellipta, Tudorza Pressair, Anoro Ellipta, roflumilast, view more... guaifenesin / theophylline, Stiolto Respimat, Striverdi Respimat, Broncomar GG, Solu-Phyllin GG, Theolate, Quibron-300, Theocon, Theophyll-GG, Rayos, Incruse Ellipta, Uni Bronchial, Broncodur, Theo G, Ed-Bron G, Equibron G, Asbron G, olodaterol, olodaterol / tiotropium, Dylix, umeclidinium, umeclidinium / vilanterol, dyphylline, aclidinium, fluticasone / vilanterol, Dilor, Lufyllin, Dilor-400, budesonide / formoterol, Slo-Phyllin GG, Lufyllin-400, Neothylline, Quibron, Elixophyllin-GG, Theomar GG, Glyceryl T